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Migraine is a common and disabling brain disorder with a broad and heterogeneous
phenotype, involving both pain and painless symptoms. Over recent years, more clinical
and research attention has been focused toward the premonitory phase of the migraine
attack, which can start up to days before the onset of head pain. This early phase
can involve symptomatology, such as cognitive and mood change, yawning, thirst and
urinary frequency and sensory sensitivities, such as photophobia and phonophobia. In
some patients, these symptoms can warn of an impending headache and therefore offer
novel neurobiological insights and therapeutic potential. As well as characterization of the
phenotype of this phase, recent studies have attempted to image this early phase using
functional neuroimaging and tried to understand how the symptoms are mediated, how a
migraine attack may be initiated, and how nociception may follow thereafter. This review
will summarize the recent and evolving findings in this field and hypothesize a mechanism
of subcortical and diencephalic brain activation during the start of the attack, including
that of basal ganglia, hypothalamus, and thalamus prior to headache, which causes
a top-down effect on brainstem structures involved in trigeminovascular nociception,
leading ultimately to headache.
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INTRODUCTION
Migraine is a disabling condition that, in addition to headache, also involves often disabling
non-headache symptoms. Although the pain phase of the migraine attack is well-recognized
and characterized by moderate to severe headache with associated sensory sensitivities such
as photophobia and phonophobia, and nausea and vomiting (1), increasingly, associated
symptomatology such as cognitive dysfunction (2) and fatigue (3) are recognized to contribute to
attack-related disability. It has been recognized for over a century that non-painful symptomatology
can precede the migraine attack (4), but only over recent decades has the phenotype and prevalence
of early attack symptoms been captured in both adults and children in detail (5–18), and the
ability to reliably and reproducibly predict headache onset has been explored (8, 9, 19). This early
phase of the migraine attack, when symptomatology outside of pain manifests, provides novel
neurobiological and therapeutic insights into possible mechanisms behind attack initiation in a
genetically predisposed individual, and into treatments that may work at aborting or preventing
pain before its onset. Given migraine therapeutics is an evolving field, fundamental understanding
of the underlying neurobiological mechanisms behindmigraine attack initiation is key to advancing
abortive therapeutics further by developing migraine-specific agents that are likely to be more
efficacious and tolerable than currently available options.
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Neurophysiological studies have suggested that the brain is
already electrically different in the lead-up to migraine pain (20–
24). One of the other ways in which the premonitory phase of
the migraine attack has been studied has been with the increasing
use of functional neuroimaging. This evolving field has allowed
understanding of human disease in patients and has been pivotal
in furthering understanding of several disorders. The functional
neuroimaging “signature” of the pain phase of themigraine attack
has been reproduced across several studies since the 1990’s (25–
29). Over the last few years, various methodologies have also been
used in imaging the premonitory phase of both spontaneous and
exogenously triggered migraine attacks and have alluded to early
involvement of subcortical diencephalic and brainstem structures
and their role in attack initiation (30).
This review will summarize these studies and hypothesize a
possible network of brain dysfunction, which starts prior to pain
onset and continues throughout migraine headache, and most
likely even following headache resolution until the brain reverts
to its true interictal state and the patient symptomatically feels
back to normal function.
PERFUSION IMAGING
Various methods of functional neuroimaging, that is, using
neuroimaging methodologies to understand human brain
function, exist. Perfusion is one measure used as a surrogate
for neuronal activity, on the basis that the more a region of
brain is active, the more blood supply that area will require
and the higher will be the regional blood flow in that area,
which can be mapped with perfusion imaging using various
modalities. One such modality is positron emission topography
(PET), which can be used to assess perfusion if used along with a
radioisotope of labeled water (H152 O). The first PET study using
blood flow measurement in the premonitory phase of migraine
was conducted in 2014 by Maniyar et al. (31). The authors used
this imaging methodology to study the premonitory phase of
nitroglycerin-triggered migraine in eight subjects in a repeated
measures design. Despite the lack of a healthy control arm,
the study was able to identify statistically significant areas of
increased blood flow during both the early and late premonitory
symptoms in the study subjects, in brain areas including the
hypothalamus, thalamus, cingulate cortex, and dorsolateral pons,
all areas that are believed to be important in the pain phase
of migraine from other studies (25–27, 32). For the first time,
this study provided a central and neuronal surrogate correlate
for what patients experience during the premonitory phase [see
Figure 1, reused with journal copyright permission, taken from
Maniyar et al. (31)].
The same authors completed additional studies looking at
some symptoms in particular, namely, nausea and photophobia.
Using similar methodologies, the authors compared subjects
with and without each symptom during the premonitory phase
to try and elucidate which part of the brain these individual
symptoms could be arising from (33, 34). The authors were
able to hypothesize that photophobia, or specifically photic
FIGURE 1 | Brain activations on PET imaging during the early premonitory
phase of nitroglycerin-triggered migraine attacks, taken from Maniyar et al. (31)
study.
hypersensitivity (that is, a sensitivity or aversion to light without
light exacerbating pain), involved the occipital lobes, which
displayed increased perfusion in subjects with the symptom
relative to those without (33). Similarly, nausea involved
activations in a region including the nucleus tractus solitarius in
the medulla, an area known as the chemoreceptor trigger zone.
This area showed increased blood flow in those with nausea
during the premonitory phase relative to those without (34).
A more recent study utilized perfusion MRI, using arterial
spin labeling (ASL), to evaluate brain blood flow changes during
the premonitory phase (35). This study again used nitroglycerin-
triggered migraine attacks, because of the logistical issues with
repeatedly and reliably capturing spontaneous premonitory
symptoms. The authors studied premonitory symptoms in
25 subjects and compared the premonitory scans following
nitroglycerin with scans obtained at the same time following
placebo in 21 subjects to correct for any possible nitroglycerin-
induced changes on cerebral blood flow. Similar areas of
increased blood flow (and therefore the suggestion of increased
neuronal activity) were identified as the Maniyar et al. study (31),
including the hypothalamus, thalamus, basal ganglia, and limbic
cortex, during the premonitory phase, supporting the theory of
subcortical brain dysfunction in migraine attack initiation.
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FUNCTIONAL MRI
The majority of the imaging work done in this field has used
functional MRI approaches—either with external stimulation or
without. The very first study was conducted by Stankewitz et al.
and did not aim to study premonitory symptoms specifically
(36). The study used trigemino-nociceptive stimulation with
intranasal gaseous ammonia in migraineurs in the interictal state,
and also in the preictal (12–48 h prior to the next migraine
attack) and ictal states in post-hoc analyses, thereby capturing
the lead-up to the headache phase of migraine. The study
showed increased neuronal activity, measured using the blood
oxygen level-dependent (BOLD) contrast signal intensity, in the
region of the spinal trigeminal nucleus in the preictal phase in
FIGURE 2 | Changes during the migraine cycle, taken from the Schulte et al. study (37). (A) Unpleasantness ratings for ammonia, rose odor, and checkerboard
stimulation (red line and dots: ammonia-ratings; green line and crosses: rose odor ratings; blue line and asterisks: checkerboard ratings), with higher values
representing a more unpleasant experience. Red areas: days of migraine pain with varying red color intensities indicating different intensities of migraine pain and blue
areas representing the last scan before onset of migraine pain. (B) Overview of the migraine cycle. (C) Results from functional MRI.
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migraineurs relative to the interictal phase and during the acute
pain phase. Rostral pontine activation was only seen during acute
pain, and not outside of pain. Interestingly, the intensity of the
BOLD signal in response to nociceptive stimulation was able
to predict the next headache, in that the stronger the BOLD
response in the region of the spinal trigeminal nuclei, the closer
the next headache would be.
Other studies have followed, studying the preictal or pre-
headache phase of the migraine attack using fMRI approaches.
An impressive study conducted by Schulte and colleagues in
2016 aimed to study further the theory of possible oscillatory
brainstem responses during the migraine cycle and studied
the same individual with daily scanning for 30 days, thereby
capturing three spontaneous migraine attacks and the periods
surrounding these (37). This study demonstrated an increase
in hypothalamic activity in the period prior to headache in
response to the same intranasal gaseous ammonia nociceptive
stimulation. There was also altered functional connectivity
between the hypothalamus and other migraine brain areas,
including the spinal trigeminal nuclei region and the dorsal
rostral pons during the day preceding headache. This study
provided additional information to the prior study and suggested
that as well as altered brainstem responses, altered hypothalamic
and brainstem connectivity could be involved in the start of a
migraine attack. Again, although this study did not phenotype the
subject extensively before the pain-free scanning days, the lead-
up phase to a migraine headache was captured and assessed using
imaging. See Figure 2, reused with journal permission, taken
from Schulte and May (37). The authors have recently presented
an extension to this work by replicating the study in a further
eight subjects who have also been imaged daily for 30 days,
with 15 spontaneous migraine attacks captured, and have found
additional results for increased functional connectivity between
the right nucleus accumbens and left amygdala, hippocampus,
and parahippocampal gyrus preictally compared with interictally,
as well as increased connectivity between the right nucleus
accumbens and dorsal rostral pons (38). These findings support
theories of dopamine pathway involvement in the premonitory
phase, as well as the involvement of the hypothalamus and
limbic pathways.
Another study followed in 2018 and was conducted
by Meylakh et al. (39). The authors used various fMRI
approaches (infraslow oscillatory activity, connectivity, and
regional homogeneity) to study spontaneous migraine preictally
and postictally, as well as interictally and in healthy controls. The
authors were able to demonstrate increased infraslow oscillatory
activity in the brainstem and hypothalamic regions just before
migraine headache, including the spinal trigeminal nucleus,
dorsal pons, and hypothalamus. There was also increased
functional coupling between these areas just before pain, as
well as increased regional homogeneity. This finding was not
present interictally, postictally, or in healthy controls. This
study provided supportive evidence for oscillatory brainstem and
hypothalamic activity in the lead-up to migraine headache and
proposed a potential role for astrocytic involvement in attack
initiation, rather than neuronal. Similarly, to previous studies,
this study did not assess functional correlation, as subjects
were not phenotyped in detail as to what, if anything, they
were experiencing symptomatically on the preictal scan days.
However, similar regions of interest emerge for the premonitory
or pre-headache lead-up to the migraine as previous studies, and
indeed as for previous migraine headache imaging studies.
A recent study performed fMRI using orofacial nociceptive
stimulation in 31 migraine patients and 31 healthy controls
during different parts of the migraine attack (40). There was an
increase in pain ratings in response to nociceptive stimulation
in the lead-up to the next migraine attack, and then these
ratings decreased immediately prior to pain. Imaging responses
in the spinal trigeminal nuclei dramatically increased in the
24 h prior to pain onset in response to noxious stimulation,
with reduced functional connectivity between this region and
the rostral ventral medulla. This study therefore suggests a
pre-headache sensitivity to pain, or reduced threshold to pain,
during the migraine attack (and therefore a susceptibility to
exogenous triggers) and the subsequent implication of altered
or dysfunctional endogenous pain modulation within the pain
network in the brain during the migraine attack or cycle, which
may be responsible for the sensation of pain felt following
premonitory symptoms. The same authors have also recently
demonstrated possible structural changes in similar brain areas
(dorsolateral pons, periaqueductal gray, and spinal trigeminal
nuclei) within 24 h of a migraine attack using mean diffusivity
and fractional anisotropy (41).
We have recently presented our resting-state fMRI results
looking at seed-based functional connectivity with the BOLD
contrast, in nitroglycerin-triggered premonitory symptoms
relative to placebo, and shown increased thalamocortical
connectivity and functional uncoupling between the pons and
the limbic lobe in the premonitory phase, with increased
functional coupling between the pons and spinal trigeminal
nuclei during migraine headache, thus suggesting changing
alterations in subcortical and brainstem networks in the
premonitory phase (42).
The imaging studies of the premonitory phase are summarized
in Table 1.
FUNCTIONAL AND NEUROBIOLOGICAL
CORRELATION WITH THE SYMPTOMATIC
PREMONITORY PHASE
Although only few of these studies, namely, the perfusion
studies, have phenotyped patients with regard to premonitory
symptomatology prior to scanning, the similarities between
implicated brain areas between all the studies and methodologies
are striking and supports a network of altered brain activity
involving pain processing, sensory integration, and limbic areas
prior to migraine pain. These regions are likely functionally
correlated to the symptomatology patients report during this
phase. It can be reasonably assumed that mood and cognitive
change may come from limbic pathway involvement, yawning
and sleep disturbance may be mediated via the hypothalamus,
and photophobia, allodynia, and other sensory sensitivities may
arise from thalamocortical connections (30, 43–47).
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TABLE 1 | Comparison of the imaging findings of the different studies examining the premonitory or lead-up to headache phase of the migraine attack.
Brain region Stankewitz
et al. (36)
Task-evoked
fMRI (trigemino-
nociceptive
stimulation)
Schulte et al. (37)
Task-evoked
fMRI (trigemino-
nociceptive
stimulation)
Schulte et al. (38)
Task-evoked fMRI
(trigemino-
nociceptive
stimulation)
Maniyar
et al. (31)
H152 O perfusion
PET (observed
triggered
attacks)
Karsan et al. (35)
Perfusion arterial
spin-labeled MRI
(observed
triggered attacks)
Meylakh et al. (39)
Resting-state fMRI
(infraslow oscillatory
activity, regional
homogeneity, and
connectivity)
Marciszewski et al. (40)
Task-evoked brainstem
responses (noxious
orofacial stimulation)
and resting-state fMRI
connectivity
Marciszewski
et al. (41)
Diffusion tensor
imaging (DTI)
and fractional
anisotropy (FA)
Karsan et al. (42)
Resting-state
BOLD-fMRI
(observed
triggered attacks)
Hypothalamus + + + + +
Thalamus + + + +
Ventral
tegmentum
+ + + + +
Caudate + +
Putamen + +
Pallidum + +
Nucleus
accumbens
+ +
Spinal trigeminal
nucleus
+ + + + +
Medulla + +
Dorsal pons + + + + + +
Frontal cortex + + +
Precuneus/cuneus + +
Cerebellum +
Anterior cingulate + + +
Occipital cortex + +
Temporal cortex,
including amygdala
and hippocampus
+ + +
The brain regions that have been suggested to be implicated in five or more studies have been highlighted in bold text.
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PREMONITORY SYMPTOMS, ATTACK
INITIATION, AND NOCICEPTION
Although the ictus of the migraine attack is usually thought of as
the pain phase, the onset of the attack could be regarded as when
the brain is different to its interictal state, and this is likely to be
days before the onset of pain, as suggested by neurophysiological
studies. How the changes in brain function occur, therefore,
are the answer to how an attack is mediated; and perhaps how
these changes go from producing premonitory symptoms to
producing pain is a second question. Many of the symptoms
that patients report during the premonitory phase, including
fatigue, cognitive dysfunction, and even photophobia, can also be
present interictally in some individuals; and in our nitroglycerin-
triggered experimental work, we have demonstrated the ability
of the drug to provoke premonitory-like symptoms with no
delayed migraine headache thereafter (48). This alludes to a
possible intra-attack threshold, which could be explained by the
oscillatory networks of brain activity demonstrated through the
imaging studies discussed in this review, and suggests that as
the networks of brain activity passing through the hypothalamus,
brainstem, and cortex change throughout the migraine cycle, so
do the pain thresholds. Although agents such as nitroglycerin
and pituitary adenylate cyclase activating peptide (PACAP)
can therefore trigger premonitory symptoms (49, 50), perhaps
the likelihood of headache following thereafter is based on
endogenous pain modulation systems and an individual’s genetic
and environmental susceptibility to developing a migraine
headache that day.
PREMONITORY SYMPTOMS AND AURA
Although in some patients aura can be a warning of an
impending headache, it is clear that aura can occur anytime
during the migraine attack and indeed in the absence of headache
too (51). Clinically, it is feasible that aura and premonitory
symptoms may seem to overlap in patients who experience
aura prior to headache. Aura is defined as the presence of
gradually developing focal and transient neurological symptoms
(1), and these can be positive or negative phenomena, whereas
premonitory symptoms suggest a more global disturbance of
brain function, without clear lateralizing neurological deficit, and
with symptoms in general lasting longer than aura and likely
occurring in a higher proportion of subjects than true migraine
aura. In addition, the current understanding of migraine aura
is that of a cortical phenomenon, characterized by cortical
spreading depression of neuronal activity, whichmost commonly
occurs in the visual cortex (52), whilst premonitory symptoms
usually coexist with each other (53) and, as discussed in
this manuscript, involve more global cortical and subcortical
brain dysfunction.
CONCLUSIONS
This review has summarized the neuroimaging literature to date
in the premonitory phase, or period leading up to pain, in
migraine. The studies have consistently provided evidence for
early brainstem involvement, as well as alluded to oscillatory
brainstem, hypothalamic, and limbic networks prior to the onset
of pain, with alterations in functional coupling between these
regions and between pain modulatory regions such as the rostral
ventral medulla and periaqueductal gray. Although the brain
areas between pre-headache and during headache are similar,
it is clear that thresholds may have a part to play in whether
pain is perceived or not, despite similar neuroimaging findings
in both the premonitory and headache phases of the attack.
There is good functional correlation between the brain areas
involved in the premonitory phase and the clinical phenotype
of what sufferers experience during the premonitory phase
of migraine.
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